Do you have any concerns about using long-acting cabotegravir/rilpivirine in obese patients with HIV?
Community PollStarted
How do you manage long-acting cabotegravir/rilpivirine administration in obese patients with HIV?
39 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Infectious Disease · University of Texas Southwestern Medical School
Answered on
There have been concerns raised about adequate drug levels being maintained in patients with high BMI. One concern is that injections may be deposited in subcutaneous rather than intramuscular tissue. A recent computer modeling study also indicated subtherapeutic drug levels in patients with BMI >40...
Join for free or sign in to see the full answer